Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • João Pedro Melo Marques Pinho Ferreira

    Autor

  • Francisco Aguiar Vasques Novoa Faria

    Autor

  • Joaquim Adelino Correia Ferreira Leite Moreira

    Autor

  • João Sérgio De Lima Soares Neves

    Autor

Participantes de fora da FMUP

  • Sharma, A
  • Butler, J
  • Packer, M
  • Zannad, F

Unidades de investigação

Abstract

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been used to reduce body weight in overweight or people with obesity and to improve glycemic control and cardiovascular outcomes among people with type 2 diabetes (T2D) and a high cardiovascular risk. However, the effects of GLP-1 RAs may be modified by the presence of heart failure (HF). In this review, we summarize the evidence for the use of GLP-1 RA across a patient's risk with a particular focus on HF. After a careful review of the literature, we challenge the current views about the use of GLP-1 RAs and suggest performing active HF screening (with directed clinical history, physical examination, an echocardiogram, and natriuretic peptides) before initiating a GLP-1 RA. After HF screening, we suggest GLP-1 RA treatment decisions as follows: (1) in people with T2D without HF, GLP-1 RAs should be used for reducing the risk of myocardial infarction and stroke, with a possible effect to reduce the risk of HF hospitalizations; (2) in patients with HF and preserved ejection fraction, GLP-1 RAs do not reduce HF hospitalizations but may reduce atherosclerotic events, and their use may be considered in an individualized manner; and (3) in patients with HF and reduced ejection fraction, the use of GLP-1 RAs warrants caution due to potential risk of worsening HF events and arrhythmias, pending risk-benefit data from further studies.

© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Dados da publicação

ISSN/ISSNe:
0021-972X, 1945-7197

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM  Endocrine Society

Tipo:
Review
Páginas:
4-9
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 2

Citações Recebidas na Scopus: 17

Documentos

  • Não há documentos

Filiações mostrar / ocultar

Keywords

  • glucagon-like peptide-1 receptor agonists; heart failure; risk modification

Financiamento

Proyectos asociados

Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684

Investigador Principal: João Pedro Melo Marques Pinho Ferreira

Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022

Estudo do tratamento da doença valvular aórtica.

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Observacional Académico (AORTA) . UniC . 2019

Eficácia da transposição de um pedículo adiposo pericárdico sobre o enfarte de miocárdio em pacientes (ensaio AGTP II)

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Ensaio Clínico Académico (Ensaio AGTP II) . 2019

Comparação de escala de qualidade de vida na insuficiência cardíaca com fração de ejeção reduzida quando realizada no domicílio ou na consulta hospitalar.

Investigador Principal: Francisco Aguiar Vasques Novoa Faria

Estudo Observacional Académico (QualidadeIC) . 2021

Early Dual Antiplatelet Therapy versus Aspirin Monotherapy after Coronary Artery Bypass Surgery: survival and safety outcomes

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico (Bypass) . 2020

Early and Midterm Outcomes following Aortic Valve Replacement with Mechanical versus Bioprosthetic Valves in Patients aged 50 to 70 Years

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico (Aortic Valve Replacemen) . 2020

Evaluation of thyroid function in patients hospitalized for acute heart failure

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico (Heart failure) . 2021

Efeito da terapêutica ß-bloqueadora pré-operatória após cirurgia de revascularização do miocárdio: sobrevida e complicações pós-operatórias

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico . 2021

Predictors Of The Effectiveness Of Insulin Pumps In Patiens With Type 1 Diabetes Mellitus

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico . 2021

Impacto da pandemia COVID-19 no controlo metabólico de doentes com Diabetes Mellitus Tipo 1

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico . 2022

Influence of Diabetes on Response to Ultrasound Guided Hydrodistension Treatment of Adhesive Capsulitis: a Retrospective Study

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico (Hydrodistension ) . 2022

"Aortic valve surgery in patients with infective endocarditis: mid-term follow-up of patients treated with the St. Jude medical trifecta™ valve"

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico . 2022

Influence of Cystic Fibrosis-Related Diabetes on the Severity of Cystic Fibrosis Phenotype

Investigador Principal: João Sérgio de Lima Soares Neves

Estudo Clínico Académico . 2022

Long-term survival after coronary artery bypass grafting: the relevance of surgical procedures analysed by propensity score methods.

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico (Arrtery bypass) . 2022

Abdominal Aortic Aneurysm - The Portuguese Case: Specificities and Consequences

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico . 2022

New Insights into Epidemiology and Pathophysiology of Abdominal Aortic Aneurysms

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico . 2021

Impacto clínico e hemodinâmico da substituição cirúrgica da válvula aórtica por biopróteses de última geração

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico . 2020

Condicionamento isquémico cardíaco remoto como adjuvante da revascularização miocárdia na doença coronário aguda

Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira

Estudo Clínico Académico . 2020

Citar a publicação

Partilhar a publicação